Long-term mortality risk in patients with an implantable cardioverter-defibrillator: Influence of heart rate and QRS duration

International Journal of Cardiology

Volumn 175, Issue 3, 2014, Pages 560-564

  Hoogwegt, Madelein T ^a,b   Theuns, Dominic A M J ^b   Pedersen, Susanne S ^a,b,c,d   Kupper, Nina ^a  

^a TILBURG UNIVERSITY   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c ODENSE UNIVERSITY HOSPITAL   (Denmark)

^d UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

Author keywords

Heart rate; Implantable cardioverter defibrillator; Mortality; QRS duration

Indexed keywords

ADULT; ANXIETY DISORDER; ARTICLE; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; COMORBIDITY; DEPRESSION; ELECTROCARDIOGRAPHY; EMOTIONAL STRESS; FEMALE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HEART RATE VARIABILITY; HOSPITAL ANXIETY AND DEPRESSION SCALE; HUMAN; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; MAJOR CLINICAL STUDY; MALE; PRIMARY PREVENTION; PRIORITY JOURNAL; PROGNOSIS; PSYCHOLOGIC ASSESSMENT; QRS COMPLEX; RESTING HEART RATE; RISK ASSESSMENT; RISK FACTOR; SECONDARY PREVENTION; AGED; ARRHYTHMIAS, CARDIAC; HEART RATE; MIDDLE AGED; MORTALITY; PATHOPHYSIOLOGY; PHYSIOLOGY; TRENDS;

AGED; ARRHYTHMIAS, CARDIAC; DEFIBRILLATORS, IMPLANTABLE; FEMALE; FOLLOW-UP STUDIES; HEART RATE; HUMANS; MALE; MIDDLE AGED; MORTALITY; RISK FACTORS;

EID: 84905099265     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2014.06.030     Document Type: Article

References (35)

1. A.J. Moss, W. Zareba, and W.J. Hall et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction N Engl J Med 346 2002 877 883
2. G.H. Bardy, K.L. Lee, and D.B. Mark et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure N Engl J Med 352 2005 225 237
3. The Antiarrrhythmics versus Implantable Defibrillators (AVID) Investigators A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias N Engl J Med 337 1997 1576 1584
4. S.S. Pedersen, C. Brouwers, and H. Versteeg Psychological vulnerability, ventricular tachyarrhythmias and mortality in implantable cardioverter defibrillator patients: is there a link? Expert Rev Med Devices 9 2012 377 388
5. R.J. Goldberg, M. Larson, and D. Levy Factors associated with survival to 75 years of age in middle-aged men and women: the Framingham study Arch Intern Med 156 1996 505 509
6. M.T. Cooney, E. Vartiainen, T. Laakitainen, A. Juolevi, A. Dudina, and I.M. Graham Elevated resting heart rate is an independent risk factor for cardiovascular disease in healthy men and women Am Heart J 159 2010 612 619 e613.
7. C.C. Lang, S. Gupta, and P. Kalra et al. Elevated heart rate and cardiovascular outcomes in patients with coronary artery disease: clinical evidence and pathophysiological mechanisms Atherosclerosis 212 2010 1 8
8. K. Fox, I. Ford, P.G. Steg, M. Tendera, M. Robertson, and R. Ferrari Heart rate as a prognostic risk factor in patients with coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a subgroup analysis of a randomised controlled trial Lancet 372 2008 817 821
9. P.G.A. Volders Novel insights into the role of the sympathetic nervous system in cardiac arrhythmogenesis Heart Rhythm 7 2010 1900 1906
10. M. Ahmadi-Kashani, D.J. Kessler, and J. Day et al. Heart rate predicts outcomes in an implantable cardioverter-defibrillator population Circulation 120 2009 2040 2045
11. E.C. Stecker, M. Zargarian, and V. Dogra et al. Native QRS duration predicts the occurrence of arrhythmic events in ICD recipients Europace 8 2006 859 862
12. L. Bode-Schnurbus, D. Böcker, and M. Block et al. QRS duration: a simple marker for predicting cardiac mortality in ICD patients with heart failure Heart 89 2003 1157 1162
13. A. Macia̧g, A. Przybylski, and M. Sterliński et al. QRS complex widening as a predictor of appropriate implantable cardioverter- defibrillator (ICD) therapy and higher mortality risk in primary prevention ICD patients Kardiol Pol 70 2012 360 368
14. M. Charlson, T.P. Szatrowski, J. Peterson, and J. Gold Validation of a combined comorbidity index J Clin Epidemiol 47 1994 1245 1251
15. A. Diaz, M.G. Bourassa, M.-C. Guertin, and J.-C. Tardif Long-term prognostic value of resting heart rate in patients with suspected or proven coronary artery disease Eur Heart J 26 2005 967 974
16. R. Kolloch, U.F. Legler, and A. Champion et al. Impact of resting heart rate on outcomes in hypertensive patients with coronary artery disease: findings from the International Verapamil-SR/Trandolapril Study (INVEST) Eur Heart J 29 2008 1327 1334
17. I. Goldenberg, A.K. Vyas, and W.J. Hall et al. Risk stratification for primary implantation of a cardioverter-defibrillator in patients with ischemic left ventricular dysfunction J Am Coll Cardiol 51 2008 288 296
18. A.S. Zigmond, and R.P. Snaith The Hospital Anxiety and Depression Scale Acta Psychiatr Scand 67 1983 361 370
19. P. Spinhoven, J. Ormel, P.P. Sloekers, G.I. Kempen, A.E. Speckens, and A.M. Van Hemert A validation study of the Hospital Anxiety and Depression Scale (HADS) in different groups of Dutch subjects Psychol Med 27 1997 363 370
20. I. Bjelland, A.A. Dahl, T.T. Haug, and D. Neckelmann The validity of the Hospital Anxiety and Depression Scale: an updated literature review J Psychosom Res 52 2002 69 77
21. D.A.M.J. Theuns, A.S. Thornton, and A.P.J. Klootwijk et al. Outcome in patients with an ICD incorporating cardiac resynchronisation therapy: differences between primary and secondary prophylaxis Eur J Heart Fail 7 2005 1027 1032
22. D.A.M.J. Theuns, B.A. Schaer, and O.I.I. Soliman et al. The prognosis of implantable defibrillator patients treated with cardiac resynchronization therapy: comorbidity burden as predictor of mortality Europace 13 2011 62 69
23. Y.G. Yap, T. Duong, and M. Bland et al. Potential demographic and baselines variables for risk stratification of high-risk post-myocardial infarction patients in the era of implantable cardioverter-defibrillator - a prognostic indicator Int J Cardiol 126 2008 101 107
24. J.E. Poole, G.W. Johnson, and A.S. Hellkamp et al. Prognostic importance of defibrillator shocks in patients with heart failure N Engl J Med 359 2008 1009 1017
25. B.D. Powell, L.A. Saxon, and J.P. Boehmer et al. Survival after shock therapy in implantable cardioverter-defibrillator and cardiac resynchronization therapy-defibrillator recipients according to rhythm shocked: the ALTITUDE survival by rhythm study J Am Coll Cardiol 62 2013 1674 1679
26. K.E. Ellison, G.E. Hafley, and K. Hickey et al. Effect of β-blocking therapy on outcome in the multicenter unsustained tachycardia trial (MUSTT) Circulation 106 2002 2694 2699
27. P.R. Kowey, H.J.G.M. Crijns, and E.M. Aliot et al. Efficacy and safety of celivarone, with amiodarone as calibrator, in patients with an implantable cardioverter-defibrillator for prevention of implantable cardioverter- defibrillator interventions or death: the ALPHEE study Circulation 124 2011 2649 2660
28. M. Habibović, S.S. Pedersen, and K.C. van den Broek et al. Anxiety and risk of ventricular arrhythmias or mortality in patients with an implantable cardioverter defibrillator Psychosom Med 75 2013 36 41
29. M.H. Mastenbroek, H. Versteeg, L. Jordaens, D.A.M.J. Theuns, and S.S. Pedersen Ventricular tachyarrhythmias and mortality in implantable cardioverter defibrillator (ICD) patients: impact of depression in the MIDAS cohort Psychosom Med 76 2014 58 65
30. M.T. Hoogwegt, S.S. Pedersen, D.A.M.J. Theuns, and N. Kupper Relation between emotional distress and heart rate variability in patients with an implantable cardioverter-defibrillator Psychophysiology 51 2014 187 196
31. M.V. Habal, P.P. Liu, and P.C. Austin et al. Association of heart rate at hospital discharge with mortality and hospitalizations in patients with heart failure Circ Heart Fail 7 2014 12 20
32. F. Custodis, S.H. Schirmer, M. Baumhäkel, G. Heusch, M. Böhm, and U. Laufs Vascular pathophysiology in response to increased heart rate J Am Coll Cardiol 56 2010 1973 1983
33. M.H.L. Van der Wal, T. Jaarsma, and D.J. van Veldhuisen Non-compliance in patients with heart failure; how can we manage it? Eur J Heart Fail 7 2005 5 17
34. M. Alvarez Moleiro, and Cid F. Villamaín Effects of biofeedback training on voluntary heart rate control during dynamic exercise Appl Psychophysiol Biofeedback 26 2001 279 292
35. N. Peira, G. Pourtois, and M. Fredrikson Learned cardiac control with heart rate biofeedback transfers to emotional reactions PLoS One 8 2013 e70004